UPXI Overview

Upexi, Inc. is a solana-focused treasury company. The Company is a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space. The Company’s brands include Lucky Tail, PRAX, and Cure Mushrooms. Lucky Tail is a pet care product brand that provides products from grooming tools to nutritional products. Cure Mushrooms is a full line of medicinal mushroom products, designed by effect for consumers, which offers mushroom extracts in tinctures and gummies. PRAX is a full line of medicinal mushroom products, designed by effect for consumers, which are cultivated, extracted, and produced in the United States. Its products are distributed in the United States of America and internationally through multiple entities and managed through locations in Florida.

Wall Street analysts forecast UPXI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UPXI is6.00 USD with a low forecast of 6.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Upexi Inc revenue for the last quarter amounts to 8.05M USD, increased 101.02

Upexi Inc. EPS for the last quarter amounts to -2.94 USD, increased 137.10

Upexi Inc (UPXI) has 59 emplpoyees as of March 11 2026.

Today UPXI has the market capitalization of 65.65M USD.